SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001559053-15-000023
Filing Date
2015-05-06
Accepted
2015-05-05 17:38:07
Documents
10
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q prta2015q110-q.htm 10-Q 756658
2 EXHIBIT 31.1 prta2015q110-qxex311.htm EX-31.1 14356
3 EXHIBIT 31.2 prta2015q110-qxex312.htm EX-31.2 14422
4 EXHIBIT 32.1 prta2015q110-qxex321.htm EX-32.1 14596
  Complete submission text file 0001559053-15-000023.txt   3970864

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT prta-20150331.xml EX-101.INS 383674
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prta-20150331.xsd EX-101.SCH 35168
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT prta-20150331_cal.xml EX-101.CAL 51080
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT prta-20150331_def.xml EX-101.DEF 118599
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prta-20150331_lab.xml EX-101.LAB 408708
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prta-20150331_pre.xml EX-101.PRE 227087
Mailing Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1
Business Address 25-28 NORTH WALL QUAY DUBLIN L2 DUBLIN 1 650-615-2119
Prothena Corp plc (Filer) CIK: 0001559053 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35676 | Film No.: 15834317
SIC: 2834 Pharmaceutical Preparations